IBER

Ibere Pharmaceuticals
IBER

Overview Fund Activity
Delisted

IBER was delisted on the 1st of March, 2023.

Back to rankings

38 hedge funds and large institutions have $71.4M invested in Ibere Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
38
Holders Change
+6
Holders Change %
+18.75%
% of All Funds
0.67%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
8
Reduced
4
Closed
–
Calls
$89K
Puts
–
Net Calls
+$89K
Net Calls Change
+$15K

Top Buyers

1
CCA
Castle Creek Arbitrage
Colorado
+$2.46M
2
Citadel Advisors
Citadel Advisors
Florida
+$2.2M
3
BCM
Basso Capital Management
Connecticut
+$1.35M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$1.32M
5
SSA
Schonfeld Strategic Advisors
New York
+$1.31M

Top Sellers

1
OPU
Omni Partners US
California
-$151K
2
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
-$46K
3
GCL
Glazer Capital LLC
New York
-$4.84K
4
AM
Ampfield Management
New York
-$10
Name Holding Trade Value Shares
Change 		Shares
Change %
Goldman Sachs
26
Goldman Sachs
New York
$543K +$12K +1,233 +2%
PI
27
PEAK6 Investments
Illinois
$484K – – –
DFCM
28
Dark Forest Capital Management
Puerto Rico
$433K +$433K +44,713 New
AM
29
Ampfield Management
New York
$432K -$10 -1 -0%
DMK
30
David M. Knott
$349K – – –
PC
31
Periscope Capital
Ontario, Canada
$291K – – –
Capstone Investment Advisors
32
Capstone Investment Advisors
New York
$242K – – –
RCM
33
Robinson Capital Management
Michigan
$160K +$160K +16,533 New
PCM
34
Prelude Capital Management
New York
$133K +$35.5K +3,634 +36%
GCL
35
Glazer Capital LLC
New York
$103K -$4.84K -497 -4%
CI Investments Inc
36
CI Investments Inc
Ontario, Canada
$49K +$49K +5,100 New
WAM
37
Wolverine Asset Management
Illinois
$29K +$29K +3,051 New
AA
38
Ancora Advisors
Ohio
$8K +$1K +100 +14%
1
2